Ani Movsisyan
Overview
Explore the profile of Ani Movsisyan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
568
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bach-Mortensen A, Verboom B, Movsisyan A, Esposti M
Nat Aging
. 2023 Apr;
1(10):948-961.
PMID: 37118328
Social care markets often rely on the for-profit sector to meet service demand. For-profit care homes have been reported to suffer higher rates of coronavirus disease 2019 (COVID-19) infections and...
12.
Rehfuess E, Movsisyan A, Pfadenhauer L, Burns J, Ludolph R, Michie S, et al.
Influenza Other Respir Viruses
. 2023 Mar;
17(3):e13110.
PMID: 36909296
Background: Public health and social measures (PHSM) intend to reduce the transmission of infectious diseases and to reduce the burden on health systems, economies and societies. During the COVID-19 pandemic,...
13.
Rehfuess E, Burns J, Pfadenhauer L, Krishnaratne S, Littlecott H, Meerpohl J, et al.
Res Synth Methods
. 2022 Jun;
13(5):558-572.
PMID: 35704478
Public health and social measures (PHSM) have been central to the COVID-19 response. Consequently, there has been much pressure on decision-makers to make evidence-informed decisions and on researchers to synthesize...
14.
Kratzer S, Pfadenhauer L, Biallas R, Featherstone R, Klinger C, Movsisyan A, et al.
Cochrane Database Syst Rev
. 2022 Jun;
6:CD015397.
PMID: 35661990
Background: With the emergence of SARS-CoV-2 in late 2019, governments worldwide implemented a multitude of non-pharmaceutical interventions in order to control the spread of the virus. Most countries have implemented...
15.
Krishnaratne S, Littlecott H, Sell K, Burns J, Rabe J, Stratil J, et al.
Cochrane Database Syst Rev
. 2022 Jan;
1:CD015029.
PMID: 35037252
Background: In response to the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the impact of coronavirus disease 2019 (COVID-19), governments have implemented a variety of measures to...
16.
Stratil J, Biallas R, Burns J, Arnold L, Geffert K, Kunzler A, et al.
Cochrane Database Syst Rev
. 2021 Sep;
9:CD015085.
PMID: 34523727
Background: Starting in late 2019, COVID-19, caused by the novel coronavirus SARS-CoV-2, spread around the world. Long-term care facilities are at particularly high risk of outbreaks, and the burden of...
17.
Klinger C, Burns J, Movsisyan A, Biallas R, Norris S, Rabe J, et al.
J Travel Med
. 2021 Aug;
28(7).
PMID: 34369562
Background/objective: International travel measures to contain the coronavirus disease of 2019 (COVID-19) pandemic represent a relatively intrusive form of non-pharmaceutical intervention. To inform decision-making on the (re)implementation, adaptation, relaxation or...
18.
Moore G, Campbell M, Copeland L, Craig P, Movsisyan A, Hoddinott P, et al.
BMJ
. 2021 Aug;
374:n1679.
PMID: 34344699
No abstract available.
19.
Movsisyan A, Burns J, Biallas R, Coenen M, Geffert K, Horstick O, et al.
BMJ Open
. 2021 Apr;
11(4):e041619.
PMID: 33837093
Objectives: To comprehensively map the existing evidence assessing the impact of travel-related control measures for containment of the SARS-CoV-2/COVID-19 pandemic. Design: Rapid evidence map. Data Sources: MEDLINE, Embase and Web...
20.
Burns J, Movsisyan A, Stratil J, Biallas R, Coenen M, Emmert-Fees K, et al.
Cochrane Database Syst Rev
. 2021 Mar;
3:CD013717.
PMID: 33763851
Background: In late 2019, the first cases of coronavirus disease 2019 (COVID-19) were reported in Wuhan, China, followed by a worldwide spread. Numerous countries have implemented control measures related to...